PLK1 and neoplasm: STAT3, an important member of the JAK/STAT signaling pathway, is negatively regulated or activated by PLK1, leading to the up-regulation of the downstream gene MMP2, thereby enhancing the aggressiveness of tumor cells (Yan et al., 2018).